BIOMAT Database Logo BIOMAT Database Logo

Transient seroreversion in children born to human immunodeficiency virus 1-infected mothers. 1992

P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Department of Pediatrics, Centre Hospitalier de Kigali, Rwanda.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Otitis media in children born to human immunodeficiency virus-infected mothers.
May 1992, The Pediatric infectious disease journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Monocyte phagolysosomal fusion in children born to human immunodeficiency virus-infected mothers.
January 1997, The Pediatric infectious disease journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi.
November 2007, Journal of acquired immune deficiency syndromes (1999),
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers.
June 2006, Virology journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Predictive value of the human immunodeficiency virus 1 antigen test in children born to infected mothers.
June 1992, The Pediatric infectious disease journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Lack of detectable human immunodeficiency virus infection in antibody-negative children born to human immunodeficiency virus-infected mothers.
March 1993, The Pediatric infectious disease journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features.
December 1992, The Pediatric infectious disease journal,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
September 1992, European journal of immunology,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothers.
December 1995, Journal of medical virology,
P Lepage, and P Van de Perre, and A Simonon, and P Msellati, and D G Hitimana, and F Dabis
Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities.
January 2000, Southern medical journal,
Copied contents to your clipboard!